Congressmen seek means of hiking FDA budget
This article was originally published in Clinica
Executive Summary
Key members of Congress are considering ways of revamping the US FDA's budget process in order to boost its resources. Senator Orrin Hatch told the Food and Drug Law Institute's annual educational conference last week that he is working on a bill with Senator Tom Harkin that would set up a so-called bypass budget for the FDA.